Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novocure Ltd Ord Sh
(NQ:
NVCR
)
12.05
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
12.05
Bid (Size)
12.07 (2)
Ask (Size)
12.16 (1)
Prev. Close
12.05
Today's Range
12.05 - 12.05
52wk Range
10.87 - 69.54
Shares Outstanding
103,647,871
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024
April 05, 2024
From
Novocure
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
April 03, 2024
Via
Benzinga
Performance
YTD
-16.32%
-16.32%
1 Month
-12.81%
-12.81%
3 Month
-2.98%
-2.98%
6 Month
-20.98%
-20.98%
1 Year
-81.07%
-81.07%
More News
Read More
Novocure to Report First Quarter 2024 Financial Results
April 01, 2024
From
Novocure
Via
Business Wire
Why NovoCure Stock Soared 18.3% This Week
March 30, 2024
Via
The Motley Fool
Why Novocure Stock Is Jumping Today
March 28, 2024
Via
The Motley Fool
Peeling Back The Layers: Exploring NovoCure Through Analyst Insights
March 27, 2024
Via
Benzinga
Novocure Stock Soars, Its Lung Cancer Electric Field Treatment Slows Progression To Brain, Data Shows
March 27, 2024
Via
Benzinga
Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday
March 27, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Novocure Surges And Flashes A Bullish Sign On Promising Results For Brain Cancer Treatment
March 27, 2024
Via
Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 27, 2024
Via
Benzinga
NovoCure Ltd. (NASDAQ: NVCR) Leading the Way in Thursday Trading Based on Percentage Gain
January 18, 2024
Via
Investor Brand Network
METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer
March 27, 2024
From
Novocure
Via
Business Wire
INNOVATE-3 Late Breaking Abstract Selected as a Best Oral Presentation at ESGO
March 11, 2024
From
Novocure
Via
Business Wire
NovoCure (NVCR) Q4 2023 Earnings Call Transcript
February 22, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 27, 2024
Via
Benzinga
Novocure Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
February 22, 2024
From
Novocure
Via
Business Wire
Earnings Scheduled For February 22, 2024
February 22, 2024
Via
Benzinga
AI Drives Tech Rebound, Oil Soars, Bitcoin Tumbles: What's Driving Markets Thursday?
January 18, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
12 Health Care Stocks Moving In Thursday's Intraday Session
January 18, 2024
Via
Benzinga
Why Is Cancer Focused Novocure Stock Trading Higher Today?
January 18, 2024
Via
Benzinga
Exposures
Product Safety
Fastenal Posts Upbeat Earnings, Joins NovoCure, Taiwan Semiconductor Manufacturing And Other Big Stocks Moving Higher On Thursday
January 18, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Novocure Announces FDA Acceptance of the PMA Application for TTFields Therapy in Non-Small Cell Lung Cancer
January 18, 2024
From
Novocure
Via
Business Wire
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 10, 2024
Via
Benzinga
Veradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesday
January 10, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Novocure Announces Last Patient Enrolled in Phase 3 TRIDENT Trial in Newly Diagnosed Glioblastoma
January 09, 2024
From
Novocure
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.